Biotoxtech Co. Ltd (086040) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩604.17 Million ≈ $409.43K USD) by net assets (₩29.25 Billion ≈ $19.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 086040 stock market capitalisation for the company's overall valuation and market capitalisation.

Biotoxtech Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Biotoxtech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biotoxtech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotoxtech Co. Ltd ranked by their cash flow conversion efficiency. Explore Biotoxtech Co. Ltd (086040) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiyuan Packaging Holdings Ltd TW:8488	0.024x
JV SPAC Acquisition Corp. Class A Ordinary Share NASDAQ:JVSA	-0.007x
Orient Precision Industries Inc KQ:065500	-0.015x
Allied Gaming & Entertainment Inc. NASDAQ:AGAE	0.000x
AVOD Kurutulmus Gida ve Tarim Urunleri Sanayi Ticaret AS IS:AVOD	0.117x
Studio Mir Co. Ltd. KQ:408900	-0.036x
Country Club Hospitality & Holidays Limited NSE:CCHHL	0.014x
ARENA.PL S.A. ZY -50 F:8G6	-0.001x

Annual Cash Flow Conversion Efficiency for Biotoxtech Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Biotoxtech Co. Ltd from 2011 to 2025. View Biotoxtech Co. Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩31.93 Billion ≈ $21.64 Million	₩6.64 Billion ≈ $4.50 Million	0.208x	+216.99%
2024-12-31	₩40.08 Billion ≈ $27.16 Million	₩-7.12 Billion ≈ $-4.83 Million	-0.178x	+47.23%
2023-12-31	₩48.23 Billion ≈ $32.69 Million	₩-16.24 Billion ≈ $-11.00 Million	-0.337x	-1037.55%
2022-12-31	₩44.23 Billion ≈ $29.98 Million	₩-1.31 Billion ≈ $-887.16K	-0.030x	-128.02%
2021-12-31	₩41.14 Billion ≈ $27.88 Million	₩4.35 Billion ≈ $2.95 Million	0.106x	-22.40%
2020-12-31	₩33.53 Billion ≈ $22.72 Million	₩4.56 Billion ≈ $3.09 Million	0.136x	+184.65%
2019-12-31	₩30.19 Billion ≈ $20.46 Million	₩1.44 Billion ≈ $978.48K	0.048x	-51.17%
2018-12-31	₩31.25 Billion ≈ $21.18 Million	₩3.06 Billion ≈ $2.07 Million	0.098x	-56.77%
2017-12-31	₩26.59 Billion ≈ $18.02 Million	₩6.02 Billion ≈ $4.08 Million	0.227x	+5.24%
2016-12-31	₩24.54 Billion ≈ $16.63 Million	₩5.28 Billion ≈ $3.58 Million	0.215x	+736.12%
2015-12-31	₩23.58 Billion ≈ $15.98 Million	₩-798.17 Million ≈ $-540.91K	-0.034x	+55.89%
2014-12-31	₩26.68 Billion ≈ $18.08 Million	₩-2.05 Billion ≈ $-1.39 Million	-0.077x	-221.95%
2012-12-31	₩25.93 Billion ≈ $17.57 Million	₩1.63 Billion ≈ $1.11 Million	0.063x	-58.32%
2011-12-31	₩21.74 Billion ≈ $14.73 Million	₩3.28 Billion ≈ $2.22 Million	0.151x	--

About Biotoxtech Co. Ltd

KQ:086040 Korea Biotechnology & Medical Research

Market Cap

$22.74 Million

₩33.55 Billion KRW

Market Cap Rank

#24797 Global

#1786 in Korea

Share Price

₩2305.00

Change (1 day)

+0.44%

52-Week Range

₩1983.00 - ₩3925.00

All Time High

₩23000.00